In support of this, the wide variation in identified expression levels in CHRM3 in colon cancer, specifically across a range of experimental methods and cell lines, suggests tissue localization may play a role in the observed changes (Felton et al., 2018; Ali et al., 2021). Here, CHRM3 is linked to colonic neoplasm.